BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 91 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $3,233,000 | +81.4% | 198,832 | +54.6% | 0.00% | +100.0% |
Q4 2021 | $1,782,000 | -45.9% | 128,643 | -43.8% | 0.00% | -50.0% |
Q3 2021 | $3,292,000 | -5.3% | 229,056 | +4.1% | 0.00% | 0.0% |
Q2 2021 | $3,478,000 | +238.0% | 220,014 | +117.4% | 0.00% | +100.0% |
Q1 2021 | $1,029,000 | +63.3% | 101,189 | +19.7% | 0.00% | – |
Q4 2020 | $630,000 | +117.2% | 84,534 | +0.2% | 0.00% | – |
Q3 2020 | $290,000 | -88.8% | 84,345 | -84.4% | 0.00% | -100.0% |
Q2 2020 | $2,583,000 | +2509.1% | 542,129 | +998.1% | 0.00% | – |
Q1 2020 | $99,000 | -9.2% | 49,368 | +56.6% | 0.00% | – |
Q4 2019 | $109,000 | -32.7% | 31,519 | -44.3% | 0.00% | – |
Q3 2019 | $162,000 | +157.1% | 56,618 | +239.9% | 0.00% | – |
Q2 2019 | $63,000 | -94.0% | 16,655 | -87.1% | 0.00% | -100.0% |
Q1 2019 | $1,053,000 | +12.4% | 129,306 | +11.4% | 0.00% | 0.0% |
Q4 2018 | $937,000 | +1042.7% | 116,110 | +712.9% | 0.00% | – |
Q2 2018 | $82,000 | +34.4% | 14,284 | +10.9% | 0.00% | – |
Q1 2018 | $61,000 | +5.2% | 12,877 | +9.9% | 0.00% | – |
Q4 2017 | $58,000 | 0.0% | 11,720 | +5.9% | 0.00% | – |
Q3 2017 | $58,000 | -60.3% | 11,072 | -26.0% | 0.00% | – |
Q3 2014 | $146,000 | – | 14,960 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |